MENINGOCOCCAL VACCINES
Clinical trials for MENINGOCOCCAL VACCINES explained in plain language.
Never miss a new study
Get alerted when new MENINGOCOCCAL VACCINES trials appear
Sign up with your email to follow new studies for MENINGOCOCCAL VACCINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New meningitis vaccine trial aims to protect toddlers
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine against a type of meningitis (ACYW135) in healthy toddlers aged 12 to 23 months. The goal is to see if the new vaccine works as well as an existing one and is safe. About 1040 children will receive two doses of either the new or the licensed vaccine…
Matched conditions: MENINGOCOCCAL VACCINES
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 06:04 UTC
-
New meningitis vaccine for kids shows promise in major trial
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine to protect children aged 2 to 6 against four types of meningococcal bacteria that cause meningitis, a serious brain infection. About 660 healthy kids will receive either the new vaccine or a licensed one, and researchers will compare immune response…
Matched conditions: MENINGOCOCCAL VACCINES
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 05:49 UTC
-
New meningitis vaccine trial for babies could offer better protection
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine against meningococcal disease (a serious infection that can cause meningitis) in healthy infants aged 6 to 11 months. About 1040 babies will receive either the new vaccine or an approved one to compare immune response and safety. The goal is to see …
Matched conditions: MENINGOCOCCAL VACCINES
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 04:37 UTC
-
New meningitis vaccine trial aims to protect infants
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine to protect babies aged 3 to 5 months against meningitis caused by four types of bacteria. About 880 healthy infants will receive either the new vaccine or an existing one, with a booster shot at 12 months. Researchers will check how well the vaccine…
Matched conditions: MENINGOCOCCAL VACCINES
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:52 UTC